Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases

• Main Authors: Anke S. Lonsdorf (Author), Dominic Edelmann (Author), Thomas Albrecht (Author), Alexander Brobeil (Author), Jannik Labrenz (Author), Moritz Johanning (Author), Richard F. Schlenk (Author), Benjamin Goeppert (Author), Alexander H. Enk (Author), Ferdinand Toberer (Author)
• Format: Book
• Published: Medical Journals Sweden, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Beyond established anti-programmed cell death protein 1/programmed cell death ligand 1 immunotherapy, T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain (TIGIT) and its ligand CD155 are promising novel inhibitory immune checkpoint targets in human mal...